rxstat › Shortages › Ezetimibe

Ezetimibe shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ezetimibe products are in shortage in Canada (4 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
4 / 18
In shortage since
Jan 14, 2022
Reports on file
88
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-EZETIMIBE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02354101 · since Feb 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
EZETIMIBE
10MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02429659 · since Jan 13, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-EZETIMIBE
10MG · TABLET · APOTEX INC
DIN 02427826 · since Dec 5, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-EZETIMIBE
10MG · TABLET · APOTEX INC
DIN 02427826 · since Jan 2, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-EZETIMIBE
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02425610 · since Jan 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Anticipated
EZETIMIBE
10MG · TABLET · SANIS HEALTH INC
DIN 02431300 · Disruption of the manufacture of the drug.
Resolved
ACH-EZETIMIBE
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02425610 · ended May 8, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
JAMP-EZETIMIBE
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02423235 · ended Mar 27, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-EZETIMIBE
10MG · TABLET · PHARMASCIENCE INC
DIN 02416409 · ended Dec 10, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-EZETIMIBE
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02419548 · ended Oct 10, 2025 · Disruption of the manufacture of the drug.
Resolved
EZETIMIBE
10MG · TABLET · SANIS HEALTH INC
DIN 02431300 · ended Sep 22, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-EZETIMIBE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02354101 · ended Sep 17, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Ezetimibe is currently affected by 4 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, SIVEM PHARMACEUTICALS ULC, APOTEX INC, ACCORD HEALTHCARE INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ezetimibe is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AX).

Recent changes

Common questions

When will Ezetimibe be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ezetimibe in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (lipid modifying agents, plain)

Partial shortageAtorvastatin11 of 64 reported products affected · est. return Jun 1, 2027Partial shortageCholestyramine Resin1 of 4 reported products affected · est. return Oct 3, 2027Partial shortageColestipol1 of 3 reported products affectedPartial shortageFluvastatin1 of 3 reported products affected · est. return Aug 31, 2026Partial shortageGemfibrozil1 of 3 reported products affectedPartial shortageLovastatin2 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.